Although not a clinical trial, and subject to various weaknesses that the authors note, overall it seems to me a good argument for most of us to be taking dutasteride?
"Our study demonstrates that 5ARI treatment can benefit patients with local and low Gleason score (≤7) PCa, especially in delaying the disease progression. More studies with larger sample size and comprehensive study design are still needed to further verify our outcomes."
Tuo Deng,#1 Xueming Lin,#2 Xiaolu Duan,1 Zihao He,1 Zhijian Zhao,1 and Guohua Zengcorresponding author1
1Department of Urology and Guangdong Key Laboratory of Urology, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China
2Department of Urology, First Hospital of Shanxi Medical University, Taiyuan, China